Babu A. Manjasetty

Babu A. Manjasetty

Auto-generated profile, based on publicly available information

Babu A. Manjasetty

European Molecular Biology Laboratory, Grenoble Outstation, 71 Avenue des Martyrs, CS 90181, 38042 Grenoble, France

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
BMBabu A. Manjasetty
Babu A. Manjasetty
JPJustin Powlowski
Justin Powlowski
AVAlice Vrielink
Alice Vrielink
The crystal structure of the bifunctional enzyme 4-hydroxy-2-ketovalerate aldolase (DmpG)/acylating acetaldehyde dehydrogenase (DmpF), which is involved in the bacterial degradation of toxic aromatic compounds, has been determined by multiwavelength anomalous dispersion (MAD) techniques and refined to 1.7-Å resolution. Structures of the two polypeptides represent a previously unrecognized subclass of metal-dependent aldolases, and of a CoA-dependent dehydrogenase. The structure reveals a mixed state of NAD+ binding to the DmpF protomer. Domain movements associated with cofactor binding in the DmpF protomer may be correlated with channeling and activity at the DmpG protomer. In the presence of NAD+ a 29-Å-long sequestered tunnel links the two active sites. Two barriers are visible along the tunnel and suggest control points for the movement of the reactive and volatile acetaldehyde intermediate between the two active sites.

1 July 2006 in Journal of Molecular Biology
Verified
Journal Article
Closed access
BMBabu A. Manjasetty
Babu A. Manjasetty
MCMark R. Chance
Mark R. Chance

22 February 2008 in Proteomics
Verified
Journal Article
Closed access
PDF file
BMBabu A. Manjasetty
Babu A. Manjasetty
ATAndrew P. Turnbull
Andrew P. Turnbull
Santosh PanjikarSantosh Panjikar
Santosh Panjikar
KBKonrad Büssow
Konrad Büssow
MCMark Chance
Mark Chance

1 October 2005 in Structure
Verified
Journal Article
Closed access
WSWuxian Shi
Wuxian Shi
CZChenyang Zhan
Chenyang Zhan
AIAlexander Ignatov
Alexander Ignatov
BMBabu A. Manjasetty
Babu A. Manjasetty
NMNebojsa Marinkovic
Nebojsa Marinkovic
MCMark Chance
Mark Chance

23 January 2004 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Open access
PDF file
BMBabu A. Manjasetty
Babu A. Manjasetty
HDHeinrich Delbrück
Heinrich Delbrück
DPDinh‐Trung Pham
Dinh‐Trung Pham
UMUwe Mueller
Uwe Mueller
MFMartin Fieber‐Erdmann
Martin Fieber‐Erdmann
UHUdo Heinemann
Udo Heinemann

11 December 2014 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
SKSanjeev Kumar
Sanjeev Kumar
SASaima Aslam
Saima Aslam
MMMohit Mazumder
Mohit Mazumder
PDPradeep Dahiya
Pradeep Dahiya
AMAruna Murmu
Aruna Murmu
SGSamudrala Gourinath
Samudrala Gourinath
Entamoeba histolytica is the etiological agent of human amoebic colitis and liver abscess, and causes a high level of morbidity and mortality worldwide, particularly in developing countries. There are a number of studies that have shown a crucial role for Ca2+ and its binding protein in amoebic biology. EhCaBP5 is one of the EF hand calcium-binding proteins of E. histolytica. We have determined the crystal structure of EhCaBP5 at 1.9 Å resolution in the Ca2+-bound state, which shows an unconventional mode of Ca2+ binding involving coordination to a closed yet canonical EF-hand motif. Structurally, EhCaBP5 is more similar to the essential light chain of myosin than to Calmodulin despite its somewhat greater sequence identity with Calmodulin. This structure-based analysis suggests that EhCaBP5 could be a light chain of myosin. Surface plasmon resonance studies confirmed this hypothesis, and in particular showed that EhCaBP5 interacts with the IQ motif of myosin 1B in calcium independent manner. It also appears from modelling of the EhCaBP5-IQ motif complex that EhCaBP5 undergoes a structural change in order to bind the IQ motif of myosin. This specific interaction was further confirmed by the observation that EhCaBP5 and myosin 1B are colocalized in E. histolytica during phagocytic cup formation. Immunoprecipitation of EhCaBP5 from total E. histolytica cellular extract also pulls out myosin 1B and this interaction was confirmed to be Ca2+ independent. Confocal imaging of E. histolytica showed that EhCaBP5 and myosin 1B are part of phagosomes. Overexpression of EhCaBP5 increases slight rate (∼20%) of phagosome formation, while suppression reduces the rate drastically (∼55%). Taken together, these experiments indicate that EhCaBP5 is likely to be the light chain of myosin 1B. Interestingly, EhCaBP5 is not present in the phagosome after its formation suggesting EhCaBP5 may be playing a regulatory role. Entamoeba histolytica is the etiologic agent of amoebiasis, a major cause of morbidity and mortality in developing countries. The genome of this organism encodes 27 EF-hand containing calcium binding proteins suggesting an intricate Ca2+ signalling system that plays crucial role in phagocytosis and pathogenesis. Calcium binding protein-5 (EhCaBP5) is one of these CaBPs that displays sequence similarity with Calmodulin (CaM) but has only two possible calcium binding EF-hand loops in two separate domains. Interestingly crystal structure of EhCaPB5 showed more structural similarity with essential light chain (ELC) of myosin than that of CaM. The binding studies of EhCaBP5 with IQ motif peptides of myosins, showed that it interacts with IQ motif of unconventional Myosin IB. A number of experiments were carried out to show that EhCaBP5 indeed binds myosin IB and that this binding is Ca2+ independent. We also show here that EhCaBP5 participates in erythrophagocytosis and that its role in phagocytosis is different from that of EhCaBP3, another myosin 1B interacting calcium binding protein of E. histolytica. Our results presented here and in a number of other reports point towards a unique phagocytic pathway involving a number of calcium binding proteins in E. histolytica.